Publications from Institute of Health and Society

• Thoresen, Lisbeth; Hofset, Berit Larsen & Rugseth, Gro (2022). Etikk ryddet av veien? En diskusjonsartikkel om . Sykepleien Forskning. ISSN 1890-2936. 17. doi: 10.4220/Sykepleienf.2022.88890. Full text in Research Archive
• Karlsen, Heidi Marie; Magelssen, Morten & Thoresen, Lisbeth (2022). Etikkdrøftinger i kommunale etikkomiteer – hva bidrar det til? En studie av helsepersonells erfaringer. Nordisk sygeplejeforskning. ISSN 1892-2678. p. 1–14. doi: 10.18261/nsf.12.2.2.
• Thoresen, Lisbeth & Røberg, Anne-Stine Bergquist (2022). The construction of the responsible patient in complex palliative care: Interpreting palliative care policies . Palliative Care & Social Practice.
• Werdofa, Hirut Megersa; Lindahl, Anne Karin; Lulseged, Belayneh & Thoresen, Lisbeth (2022). Women’s perspectives on disrespect and abuse experiences during childbirth in a teaching hospital in Southwest Ethiopia: A qualitative study. Sexual and Reproductive Health Matters (SRHM). ISSN 2641-0397. doi: 10.1080/26410397.2022.2088058.
• Asaduzzaman, Muhammad; Rødland, Ernst Kristian; Mekonnen, Zeleke; Gradmann, Christoph & Winkler, Andrea Sylvia (2022). Understanding transmission pathways and integrated digital surveillance potential of antimicrobial resistance in Ethiopia in a One Health approach: a mixed-method study protocol. BMJ Open. ISSN 2044-6055. 12. doi: 10.1136/bmjopen-2021-051022. Full text in Research Archive Show summary

  Introduction Antimicrobial resistance (AMR) has a critical global impact, mostly affecting low- and middle-income countries. A major knowledge gap exists in understanding the transmission pathway of the gut colonisation with AMR bacteria between healthy humans and their animals in addition to the presence of those AMR bacteria in the surrounding environment. A One Health (OH) approach is necessary to address this multisectoral problem. Methods and analysis This cross-sectional, mixed-method OH study design will use both quantitative and qualitative methods of data collection. Quantitative methods will be carried out to assess the prevalence and risk factors associated with multidrug resistant Gram-negative bacteria and vancomycin-resistant enterococci in humans, animals (cattle) and the environment. The focus will be on cattle rearing as an exposure risk for AMR among humans. The assessment of AMR in the population of Jimma, Ethiopia with or without exposure to cattle will reinforce the importance of OH research to identify the impending exchange of resistance profile between humans and animals as well as its ultimate dissemination in the surrounding environment. The targeted semistructured key stakeholder interviews will aid to strengthen the OH-AMR surveillance in Ethiopia by understanding the acceptability of an integrated AMR surveillance platform based on the District Health Information Software-2 and the feasibility of its context-specific establishment. Ethics and dissemination The study has been approved by the Regional Ethics Committee, Norway, and the Institutional Review Board of Jimma University, Ethiopia. The study’s data will be stored on a secure server known as Services for Sensitive Data hosted by the University of Oslo. In addition, the new European Union Global Data Protection Guidelines for data sharing, storage and protection will be followed. We will publish the results in peer-reviewed journals and present the findings at national and international conferences.

• Hartman, Esther; Groen, Wim; Heltveit-Olsen, Silje Rebekka; Lindbæk, Morten; Høye, Sigurd & Skoglund, Ingmarie [Show all 16 contributors for this article] (2022). Decisions on antibiotic prescribing for suspected urinary tract infections in frail older adults: a qualitative study in four European countries. Age and Ageing. ISSN 0002-0729. 51(6). doi: 10.1093/ageing/afac134.

View all works in Cristin

• Solberg, Carl Tollef (2022). Klare for å ta imot saker . [Internet]. Drammen Kommune. Show summary

  Etikkrådet for helse og omsorg er etablert, og etiske dilemmaer kommer med det enda høyere opp på dagsorden i Drammen kommune. Nå er rådet klare for å ta imot saker.

• Solberg, Carl Tollef & Brækhus, Leni Aurora (2022). Studie: En av tre vil ha «ja» til dyr og lite effektiv medisin. [Newspaper]. Dagens Medisin. Show summary

  Halvparten aksepterer «nei» til dyr og lite effektiv kreftmedisin, og syv av ti vil øke finansieringen til den offentlige helsetjenesten. Dette viser en ny norsk studie av folks holdninger til prioriteringer.

• Solberg, Carl Tollef (2022). Hvem bør vi prioritere? Dilemmaer i kommunehelsetjenesten.
• Solberg, Carl Tollef (2022). Hva er etikk? .
• Houge, Anette Bringedal & Laugerud, Solveig (2022). A crime too ordinary: reflections on 'ordinary' sexual violence in the Norwegian context [panel].
• Kinge, Jonas Minet & Flatø, Martin (2022). Helseforskjeller starter i barndommen. Dagbladet. ISSN 0805-3766.
• Hellesø, Ragnhild; Henni, Silje Havrevold; Ansteinsson, Vibeke Elise; Hovden, Ewa Alicja Szyszko & Skudutyte-Rysstad, Rasa (2022). Connecting ORAL health- and home healthcare service for patients receiving home healthcare in Norway.
• Ansteinsson, Vibeke Elise (2022). CORAL prosjektet: Design av en kompleks intervensjon gjennom samskaping.
• Houge, Anette Bringedal (2022). A.B.Houge svarer 07.06.2022. Tidsskrift for Den norske legeforening. ISSN 0029-2001. Show summary

  Tilsvar til kommentar til min artikkel "Helseattest for eldre bilførere" fra Morten Nordby med overskrift "Unyansert og ikke valid"

• Houge, Anette Bringedal (2022). A.B. Houge svarer 08.04.2022. Tidsskrift for Den norske legeforening. ISSN 0029-2001. Show summary

  Tilsvar til kommentar til min artikkel "Helseattest for eldre bilførere" fra Torkel Steen med overskrift "Er leger de rette til å vurdere faktisk kjøreevne?"

• Hofmann, Bjørn Morten (2022). Amended HTA using the VALIDATE framework.
• Bakken, Anne Karen; Mengshoel, Anne Marit; Synnes, Oddgeir & Strand, Elin Bolle (2022). Narratives of change in recovery from severe fatigue - a qualitative study on stories of healing from severe chronic fatigue syndrome/myalgic encephalomyelitis. Journal of Psychosomatic Research. ISSN 0022-3999. 157.
• Holvik, Kristin; Ellingsen, Christian Lycke; Solbakken, Siri Marie; Finnes, Trine Elisabeth; Talsnes, Ove & Grimnes, Guri [Show all 9 contributors for this article] (2022). Causes of death and cause-specific excess mortality after hip fracture. The Norwegian Epidemiologic Osteoporosis Studies (NOREPOS). Show summary

  Introduction: Hip fracture is a serious injury which affects older multimorbid patients and involves excess mortality. We aimed to describe leading causes of mortality through the first year after a hip fracture. Material and Methods: Hospital-treated hip fractures in Norway 1999-2016 were linked with age- and sex-matched population controls and the Norwegian Cause of Death Registry through 2017. Underlying causes of death were coded according to ICD-10 and grouped by the Eurostat shortlist. Results: Of 146,132 Norwegians with a first incident hip fracture, 35,498 (24.3%) died within one year. By 30 days post-fracture, external causes (usually the fall causing the fracture) were defined as the underlying cause for 53.8% of deaths, followed by circulatory diseases (19.8%), neoplasms (9.4%), respiratory diseases (5.7%), mental and behavioral disorders (2.0%) and diseases of the nervous system (1.3%). By one year post-fracture, external and circulatory causes together accounted for half of deaths (26.1% and 27.0%, respectively). For causes other than external causes, one-year relative mortality risks in hip fracture patients compared with population controls ranged from 1.5 for circulatory diseases to 2.5 for diseases of the nervous system in women. In men, the corresponding relative risks ranged from 2.4 for circulatory diseases to 5.3 for diseases of the nervous system. Conclusions: Hip fractures entail high excess mortality from all major causes of death. However, the traumatic injury of a hip fracture is the leading underlying cause of death the first year after the fracture, underlining the importance of preventing falls and fractures in older adults.

• Riska, Brit Solvor Lyse; Holvik, Kristin; Gunnes, Nina; Omsland, Tone Kristin; Stigum, Hein & Meyer, Haakon Eduard [Show all 7 contributors for this article] (2022). Risk of hip fracture in Norwegians using anti-osteoporosis medication. Show summary

  Introduction: Norway has a high hip fracture incidence. Clinical trials have demonstrated fracture-preventive effects of bisphosphonates (BPs) and denosumab (DMab). We aimed to investigate whether BPs and DMab used in the population of Norway reduce risk of first-time hip fracture when adjusting for morbidity. Material and methods: Demographic information from participants in the Population and Housing Census 2001 who were alive and resident by 1 January 2005 was linked with filled prescriptions in the Norwegian prescription database (2005-2016) and the NOREPOS hip fracture database. Persons 50 years and older were included starting from January 2005 and observed through December 2016. Sex-stratified time-to-event analysis was used with age as time scale and time-varying exposure to BPs and DMab. The medication-based Rx-Risk Comorbidity Index was added as a time-varying covariate. Other covariates were marital status, education, and exposure to BPs/DMab with another indication than osteoporosis. Results: Of 1,044,661 women and 1,040,782 men, 74,775 (7.2%) and 13,417 (1.3%), respectively, were ever-users. Age-adjusted hazard ratio (HR) of hip fracture in women was 1.20 (95 % CI: 1.15–1.26) when using BPs, and HR 0.74 (0.55–0.99) when using DMab. Fully adjusted HRs were 1.01 (0.96–1.06) and 0.62 (0.46–0.83) respectively. For men exposed to BPs, HR was well above 1 – also when adjusted. Conclusions: In population-wide real-world data, women exposed to BPs had a hip fracture risk around the same level as the unexposed population after adjusting for comorbidity. Exposure to DMab was associated with a lower risk of hip fracture in women.

View all works in Cristin